| | | | | |

Home-Based Rehab Helps Mesothelioma Patients Bounce Back After Chemotherapy

ByAlex Strauss

New evidence suggests that a pulmonary rehabilitation program that comes to them might help patients recover after pleural mesothelioma treatment.

Experts in pulmonary cancers at several French institutions recently published what they called a “real-life feasibility study” of home-based rehab in patients who had received chemotherapy for either lung cancer or malignant pleural mesothelioma.

Previous research has shown that these patients are typically less physically active and experience a lower quality of life as a result of the cancer and/or the treatment.

Managing Mesothelioma Rehabilitation at Home

In the new French study, patients who had undergone chemotherapy for lung cancer or pleural mesothelioma were screened to see if they would be good candidates for a rehabilitation program offered in their homes. A total of 243 patients were considered eligible, but only 71 elected to participate.

The program included exercise training as well as education about their therapy and recovery and “psychosocial” management to help patients cope with the mental and relational stresses that can accompany mesothelioma treatment.

Mesothelioma patients were also led through a series of exercise tolerance tests, including a 6-minute walk test and a 6-minute stepper test. The baseline walking distance was found to be related to overall health and shortness of breath, but not to cancer stage.

The “feasibility and safety” of the program were evaluated based on how diligent the participants were at attending the sessions and adhering to the program and whether or not their activity and/or quality of life improved.

Program Deemed “Feasible and Safe” for Mesothelioma Patients

Although fewer than a third of the eligible patients chose to participate in the home-based pulmonary rehabilitation program—and even fewer (47) completed it—mesothelioma patients who did fully participate saw improvement in both their activity levels and their anxiety.

None of the mesothelioma patients experienced any negative side effects from participating in the program and most also showed improvement in their 6-minute walk and stepper tests.

The researchers conclude that pulmonary rehabilitation offered at home “might be beneficial” for improving both health and quality of life after mesothelioma treatment, but that further studies are warranted.

Movement Speeds Recovery After Mesothelioma Treatment

Whether or not they engage in a formal pulmonary rehabilitation program, cancer doctors typically recommend that mesothelioma patients get regular exercise to counter the fatigue, muscle weakness, and decreased quality of life that can accompany treatment. All of these symptoms can worsen when patients are sedentary.

Because shortness of breath (dyspnea) and fatigue are common in people undergoing treatment for mesothelioma, patients are advised to stay active by engaging in low-impact activities such as walking, swimming, gentle yoga, or Tai chi.

The National Comprehensive Cancer Network recommends 30 minutes of activity, five days a week for people with mesothelioma and other types of cancer.

Sources:

Olivier, C, et al, “Real-life feasibility of home-based pulmonary rehabilitation in chemotherapy-treated patients with thoracic cancers: a pilot study”, February 13, 2017, BMC Cancer

“Exercise During Cancer Treatment”, Patients and Caregiver Resources, National Comprehensive Cancer Network

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    ByAlex Strauss

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    ByAlex Strauss

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…